Mouse model of Hutchinson-Gilford progeria syndrome shows reduction in hepatic H2S levels

FHS
July 12, 2023
3:10 am

A new research paper was published in Aging (listed by MEDLINE/PubMed as “Aging (Albany NY)” and “Aging-US” by Web of Science) Volume 15, Issue 12, entitled, “Hepatic hydrogen sulfide levels are reduced in mouse model of Hutchinson-Gilford progeria syndrome.”

COVID-19 Impaired Fertility Treatments

Couples infected with the COVID-19 virus while receiving assisted reproductive technology treatment had lower quality embryo and blastocyst rates when compared to non-infected couples, a

July 14, 2023

Pharmalittle: More U.S. states and cities are suing insulin makers; Biden looks to boost U.S. drug manufacturing amid shortages

Top of the morning to you, and a fine one it is. Cool breezes and clear blue skies are wafting above the Pharmalot campus, where

November 28, 2023

The lessons of Aduhelm, Biogen’s Alzheimer’s drug that was not to be

Aduhelm, a pioneering treatment for Alzheimer’s disease that collapsed under corporate mistakes and regulatory controversy, is now a cautionary tale in pharmaceutical history. This week

February 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.